Original articleSodium Correction Practice and Clinical Outcomes in Profound Hyponatremia
Section snippets
Study Design and Setting
Our study was a retrospective analysis of our longstanding electronic medical record (EMR) system at the Rochester campus of Mayo Clinic. The local institutional review board reviewed and approved the project. We performed a search of the EMR to identify all patients admitted to our institution from January 1, 2008, through December 31, 2012, with a serum sodium level less than 120 mmol/L after correction for serum glucose using a well-described correction factor.15 We excluded patients younger
Results
The Figure shows how patients were identified for inclusion in the study, as well as their subsequent grouping according to degree of sodium correction at 24 hours. A total of 412 patients were included; 211 patients (51.2%) had optimally corrected hyponatremia at 24 hours, 87 patients (21.1%) had undercorrected hyponatremia, and 114 (27.7%) had overcorrected hyponatremia according to our predefined criteria. The closest sodium measurements to the 24-hour mark (used to estimate Na24) were a
Discussion
Our results indicate that nonoptimal correction of hyponatremia was very common in patients admitted with profound hyponatremia, occurring in nearly half of the patients in this cohort. Although it was frequent, overcorrection was associated with only a single case of ODS (corresponding to an incidence of approximately 1% in those who were overcorrected) and was not associated with changes in hospital mortality or LOS. Hospital LOS was increased in patients who met our definition of
Conclusion
In the current study, we identified a high rate of nonoptimal sodium correction during the first 24 hours of treatment in a large unselected cohort of patients admitted to our institution with profound hyponatremia during a 5-five year period. Fortunately, this high rate of nonoptimal correction was not associated with increased in-hospital mortality and seemed to be associated with morbidity only infrequently—ODS occurred in only a single patient, corresponding to an incidence of approximately
Acknowledgments
The authors gratefully acknowledge the entire Multidisciplinary Epidemiology and Translational Research in Intensive Care research group for their support, which made this project possible. The authors also thank Mayo Clinic's Center for Translational Science Activities for their support. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
References (24)
- et al.
The treatment of hyponatremia
Semin Nephrol
(2009) Quantitative approaches to the analysis and treatment of the dysnatremias
Semin Nephrol
(2009)- et al.
Hyponatremia: evaluating the correction factor for hyperglycemia
Am J Med
(1999) - et al.
Clinical and radiologic correlations of central pontine myelinolysis syndrome
Mayo Clin Proc
(2011) - et al.
Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records
Mayo Clin Proc
(2012) - et al.
Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia
Am J Kidney Dis
(2013) - et al.
Hyponatremia treatment guidelines 2007: expert panel recommendations
Am J Med
(2007) - et al.
Incidence and etiology of hyponatremia in an intensive care unit
Clin Nephrol
(1990) - et al.
Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change
Crit Care
(2013) - et al.
Diagnosis and management of hyponatremia in acute illness
Curr Opin Crit Care
(2008)
Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women
N Engl J Med
Predictors of outcome in hospitalized patients with severe hyponatremia
J Natl Med Assoc
Cited by (0)
For editorial comment, see page 1320
Grant Support: The work was supported by the Mayo Clinic's Center for Translational Science Activities grant UL1 TR000135 from the National Center for Advancing Translational Sciences.